Depth of response (CR/VGPR, MRD-) links to better outcomes, while biochemical progression predicts end-organ damage. Higher MHC-I on tumors and greater GZMB+ T cells in clonally expanded CD8 ...

The combination of talquetamab and teclistamab “warrants further investigation in patients with relapsed or refractory multiple myeloma,” according to researchers.

The combination of a talquetamab and teclistamab induced durable responses among patients with relapsed or refractory ...

We described the first case reported in the literature of multiple myeloma in a young African woman with Systemic lupus and Sjögren Syndrome. The clinician should consider multiple myeloma in young ...

Danielle, who lives in Castleford, West Yorkshire, was suffering with constant colds, headaches, fatigue, unexplained rashes, sinus infections, and other mysterious illnesses. After visiting the ...

What Is an HIV Rash? An HIV rash is irritated skin that affects people who have HIV. It can be itchy, red or purple, or painful. Most people who have HIV get a rash at some point. It’s a common ...

Eventually, I became so thin that I fainted,” Han said. Han suffered from a rash of an unknown cause, which took seven years to heal. She also had patulous eustachian tube syndrome, a rare ...